Blau Farmacêutica S.A.
São Paulo Stock Exchange BLAU3.SA
Blau Farmacêutica S.A. Price to Sales Ratio (P/S) on January 14, 2025: 1.28
-
Blau Farmacêutica S.A. 52-week high Price to Sales Ratio (P/S) is 1.95 on January 15, 2024, which is 51.97% above the current Price to Sales Ratio (P/S).
-
Blau Farmacêutica S.A. 52-week low Price to Sales Ratio (P/S) is 1.10 on June 20, 2024, which is -14.69% below the current Price to Sales Ratio (P/S).
-
Blau Farmacêutica S.A. average Price to Sales Ratio (P/S) for the last 52 weeks is 1.45.
| Date | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield |
|---|
| CEO | Mr. Marcelo Rodolfo Hahn |
| IPO Date | April 19, 2021 |
| Location | Brazil |
| Headquarters | Rodovia Raposo Tavares, 2833, km 30,5 |
| Employees | 1,900 |
| Sector | Health Care |
| Industries | |
Blau Farmacêutica S.A., a pharmaceutical company provides private label drugs in Brazil, Argentina, Colombia, the United States, Ecuador, Peru, and Uruguay. The company's medications cover various therapeutic classes, such as immunology, hematology, oncology, nephrology, specialties, and antibiotics. It also offers biological drugs; oral and injectable drugs for treating cancer; specialized treatments for infectious diseases; and prescription and non-prescription drugs, including dermo-medicines, condoms, and others for retail and non-retail markets. In addition, the company provides blood-derived, biological, biotechnological, and antiretroviral drugs. It serves hospitals, private clinics, chemotherapy and hemodialysis centers, and public health institutions. The company was incorporated in 1987 and is headquartered in Cotia, Brazil.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email